About the Product

Description


Dozyfyle 200 Tablet containing Doxofylline is used for the management of asthma and other obstructive airway diseases. It helps improve airflow and supports better respiratory function.

Doxofylline works as a bronchodilator by relaxing the smooth muscles of the airways, helping reduce airway constriction and making breathing easier in susceptible patients.

The tablet is widely prescribed in respiratory and general medicine practice for the management of chronic respiratory conditions requiring bronchodilator therapy, leading to consistent prescription demand.

With the increasing prevalence of respiratory disorders and growing demand for effective airway management therapies, this product offers strong business potential for retailers and distributors. Its established therapeutic efficacy, broad clinical relevance, and steady market demand make it a reliable product for growth in the respiratory care segment.

Some patients may experience nausea, vomiting, headache, dizziness, stomach discomfort, insomnia, palpitations, or nervousness. Rarely, cardiac rhythm disturbances, severe allergic reactions, or seizures may occur and require immediate medical attention.

Dozyfyle 200 Tablet is indicated for bronchial asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, and other respiratory disorders associated with reversible airway obstruction. It helps relieve wheezing, shortness of breath, chest tightness, and breathing discomfort.

This medicine should be used strictly under medical supervision. Use cautiously in patients with heart disease, hypertension, liver impairment, kidney disease, hyperthyroidism, or seizure disorders. Avoid exceeding the prescribed dosage, as higher doses may increase the risk of adverse effects. Follow the treatment plan advised by your healthcare professional.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Doxofylline 200mg Tablet in the PCD pharma franchise market?

Doxofylline 200mg Tablet has strong demand in the respiratory care, pulmonology, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on asthma and respiratory health portfolios.

Why should medical distributors include Doxofylline 200mg Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for airway disease management under medical supervision. Doxofylline 200mg is a bronchodilator that helps relax the muscles of the airways and improve breathing Commonly prescribed for bronchial asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders associated with bronchospasm Helps improve airflow and reduce breathing difficulties Oral tablet formulation offers convenient administration and supports long-term respiratory care This strengthens a comprehensive respiratory and pulmonary care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Doxofylline 200mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from steady prescription demand in pulmonology and general medicine, repeat therapy usage, reliable supply chain support, strong market acceptance, and attractive margins in the respiratory care segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.